APA (7th ed.) Citation

JL, C., WY, L., RT, L., SH, J., & CL, L. (2024). Safety and Tolerability of Anti-microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study. Clinical therapeutics, 46(10), 768. https://doi.org/10.1016/j.clinthera.2024.08.015

Chicago Style (17th ed.) Citation

JL, Chen, Lai WY, Lin RT, Juo SH, and Liang CL. "Safety and Tolerability of Anti-microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study." Clinical Therapeutics 46, no. 10 (2024): 768. https://doi.org/10.1016/j.clinthera.2024.08.015.

MLA (9th ed.) Citation

JL, Chen, et al. "Safety and Tolerability of Anti-microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study." Clinical Therapeutics, vol. 46, no. 10, 2024, p. 768, https://doi.org/10.1016/j.clinthera.2024.08.015.